首页> 外文期刊>The Journal of Immunology: Official Journal of the American Association of Immunologists >Mechanisms of acquired thymic tolerance in vivo: intrathymic injection of antigen induces apoptosis of thymocytes and peripheral T cell anergy.
【24h】

Mechanisms of acquired thymic tolerance in vivo: intrathymic injection of antigen induces apoptosis of thymocytes and peripheral T cell anergy.

机译:体内获得胸腺耐受的机制:胸腺内注射抗原诱导胸腺细胞凋亡和外周T细胞无反应性。

获取原文
获取原文并翻译 | 示例
           

摘要

Intrathymic injection of Ag induces Ag-specific tolerance in several clinically relevant experimental autoimmune and transplantation models. However, the exact mechanisms of acquired thymic tolerance in vivo remain unclear. We investigated the mechanisms of acquired thymic tolerance in mice that are transgenic for the TCR specific for peptide 323-339 of OVA. Intrathymic injection of OVA leads to apoptosis of thymocytes starting as early as 3 h after injection and persisting up to 7 days. Double positive thymocytes undergo apoptosis earlier than single positive thymocytes, and significantly higher percentages of double positive thymocytes ultimately die as compared with single positive cells. Apoptotic cells show decreased surface expression of CD4. In the periphery, T cells from intrathymically injected animals had suppressed proliferation and IL-2 production to OVA compared with T cells from control Ag-injected mice. We conclude that intrathymic injection of Ag induces apoptosis of immature thymocytes and a subpopulation of mature thymocytes and induces prolonged anergy in peripheral T cells in vivo. Understanding the mechanisms of acquired thymic tolerance may lead to development of novel clinical strategies to prevent autoimmune disease and transplant rejection.
机译:在一些临床相关的实验性自身免疫和移植模型中,胸腺内注射Ag可诱导Ag特异性耐受。但是,体内获得性胸腺耐受的确切机制仍不清楚。我们研究了对OVA肽323-339特异的TCR转基因的小鼠获得性胸腺耐受的机制。胸腺内注射OVA导致胸腺细胞凋亡最早在注射后3小时开始,并持续长达7天。双阳性胸腺细胞比单阳性胸腺细胞更早地发生凋亡,并且与单阳性胸腺细胞相比,双阳性胸腺细胞的死亡最终显着更高。凋亡细胞显示CD4的表面表达降低。与来自注射Ag的对照小鼠的T细胞相比,在胸腺内注射的动物的T细胞在外周抑制了增殖和IL-2向OVA的产生。我们得出的结论是,胸腺内注射Ag会诱导未成熟胸腺细胞的凋亡和成熟胸腺细胞的亚群,并在体内诱导外周T细胞的无反应。了解获得性胸腺嘧啶耐受的机制可能导致开发预防自身免疫性疾病和移植排斥的新型临床策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号